Infliximab

Tax included
Infliximab (Avakine) is a chimeric monoclonal IgG1 antibody that specifically binds to TNF-α. Infliximab prevents the interaction of TNF-α with TNF-α receptor (TNFR1 and TNFR2). Infliximab has the potential for autoimmune, chronic inflammatory diseases and diabetic neuropathy research.
MedChemExpress 
HY-P9970

Data sheet

Size
Multiple sizes
Reactivity
TNF Receptor; Bacterial
Application
Metabolism-sugar/lipid metabolism
CAS
170277-31-3